Newest Technologies Target Neuroendocrine Tumors STORY HIGHLIGHTS Diagnosis and treatment of neuroendocrine tumors, which are the second most common mass that forms in the pancreas, require special expertise and a multidisciplinary team. Leveraging its institutional strengths in nuclear medicine, gastrointestinal and pancreatic surgery, medical oncology, endocrinology and liver surgery and transplantation, UCLA has established a dedicated program to improve the care of patients with neuroendocrine tumors. These are relatively uncommon tumors that A patient with a pancreatic NET was referred for restaging. Corresponding 68Ga-DOTATATE scan revealed multiple bone and liver metastases as can be seen on the maximum intensity projection (left panel) as well as on the corresponding fused PET/CT images (right panel). UCLAHEALTH.ORG 1-844-4UCLADR (1-844-482-5237) can arise throughout the body, but particularly affect the gastrointestinal tract, and are the second-most common masses that form in the pancreas. The diagnosis and treatment of neuroendocrine tumors require special expertise and a multidisciplinary team. While focused on many of the experimental treatments that